Movement Disorders Grand Rounds Live

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Cleveland Clinic Foundation accredited by the ACCME to provide continuing medical education to physicians.

Each activity offers up to 1.0 credit for Physicians (AMA PRA Category 1 Credits™), Nurses (ANCC Contact Hours), Interprofessional learners (IPCE Credits), and Certificates of Participation.

 

As an accredited provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME) the University of Nevada, Reno School of Medicine must ensure balance, independence, objectivity, and scientific rigor in all its educational activities. In order to assure that information is presented in a scientific and objective manner, The University of Nevada, Reno School of Medicine requires that anyone in a position to control or influence the content of a continuing medical education activity disclose relevant financial relationships with any commercial or proprietary entity producing health care goods or services relevant to the content being planned or presented. Following are those disclosures.

All presenters, planners or anyone in a position to control the content of this continuing medical education activity have disclosed all affiliations/financial interests (if any) and indicated whether they or their spouse/legally recognized domestic partner has any financial relationships with commercial interests related to the content of this activity.

Diagnosis of Dementia:

Kester and Scheltens. Neurolin ClinPract 2009

Kesteret al, Neurolin Practice. 2009; 9 Schneider et al, Brain. 2012 Oct

Harvey et al, J NeurolNeurosurgPsychiatr 2003; 74

Roman et al 1993

RadiologyTutorials.com

McKeithet al. Neurology 1996

Bradshaw et al, JNNP 2004

Snowden et al, Brain. 2006; 129

Boeve et al, Neurology. 2001; Oct 23

Relkinet al, Neurosurgery 2005

Shprecher et. al, CurrNeurol 2008

 

Redefining Alzheimer’s Disease: Prodromal Alzheimer’s Disease

 

Boyle et al. AnnalNeurol2018

© JL Cummings, 2008

Luck et al 2010

Roberts et al 2014

Eckerstrom et al 2010

Hansson et al, Lancet Neurol 2006; 5: 228–234

Sunderland et al, JAMA2003

Coleman, Neuroimaging Clinic NA2005

Patwardhanet al, Radiology2004

Florida Alzheimer’s Disease Research Center

 

Barnes et al. Lancet Neurol2011

Douaud et al. PNAS 2013

Dysken et al. JAMA 2014

Cognitive -Vitality. (2012). AlzDiscovery.Org/Cognitive-Vitality. https://AlzDiscovery.org/Cognitive-vitality

 

Differential Diagnosis of Dementia

Kester and Scheltens. Neurolin ClinPract 2009

Fermanet al. Neurology 77(9): 875–882, 2011

Mathew et al. JNNP 2012

Yagishitaet al. Neurology2005

Righiniet al. AJNR2004

Diagnostic Criteria | Creutzfeldt-Jakob Disease, Classic (CJD) | Prion Disease | CDC. (2012). https://www.cdc.gov/prions/cjd/diagnostic-criteria.html

www.ajnr.org/content/27/7/1459

 

Treatment of Dementia

Newman et al. Front Behav Neurosci 2012

Stanciu et al. Biomolecules 2019

Doraiswamy et al. Prog Neuropsychopharmacol Biol Psychiatry 2002

Stefanova et al. J Neural Transm 2006

Mega et al.  Arch Neurol 2005

Tariot et al. JAMA 2004

Sultzer et al. Amer J Ger Psych 2010

Howard et al. NEJM 2012

[Prescribing Information] Accera Inc. 2009.

 

Behavioral and Psychiatric Syndromes of Dementia

Craig D, et al. Am J Geri Psychiatry 2005; 13: 460

 

Robert et al. European Psychiatry 2009

Ballard et al. J Clinical Psychiatry 2002

Holmes et al. International J GeriatrPsychiatry 2002

International Psychogeriatric Association. The IPA Complete Guides to BPSD –Specialist’s Guide 2013

Stroud. J Neurol 2010

Cerejeiraet al. Frontiers in Neurology 2012

Wang et al. Current Neuropharmacology 2016

Wang et al. Current Neuropharmacology 2016

Schneider et al. Am J GeriatrPsychiatry 2006

Ballard et al. Nat Rev Neurosci 2006

Street et al. Arch Gen Psychiatry 2000

Katz et al. J ClinPsychiatry 1999

Rochonet al. Arch IntMed 2008

Camargos 2014. Sasada 2013. Stahl 2009

Theleritiset al. J GeriatrPsychiatry and Neurol 2017

Cummings et al. JAMA 2015

Wang et al. Am J GeriatrPsychiatry 2009

Bachinskaya et al. Neuropsychiatr Dis Trt 2012

Rosenberg. J Clin Psychiatry 2013

Porsteinsson. Exp Opin Pharmacotherapy 2017

 

Motor and Visuospatial Syndromes of Dementia

McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):263-269.

Bondi MW, Edmonds EC, Salmon DP. Alzheimer’s Disease: Past, Present, and Future. J Int Neuropsychol Soc. 2017;23(9-10):818-831.

Jack CR, Jr., Holtzman DM. Biomarker modeling of Alzheimer’s disease. Neuron. 2013;80(6):1347-1358.

Jak AJ, Bangen KJ, Wierenga CE, Delano-Wood L, Corey-Bloom J, Bondi MW. Contributions of neuropsychology and neuroimaging to understanding clinical subtypes of mild cognitive impairment. Int Rev Neurobiol. 2009;84:81-103.

Petersen RC, Knopman DS. MCI is a clinically useful concept. Int Psychogeriatr. 2006;18(3):394-402; discussion 409-314.

Cerhan JR, Folsom AR, Mortimer JA, et al. Correlates of cognitive function in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Gerontology. 1998;44(2):95-105.

Callahan CM, Hall KS, Hui SL, Musick BS, Unverzagt FW, Hendrie HC. Relationship of age, education, and occupation with dementia among a community-based sample of African Americans. Arch Neurol. 1996;53(2):134-140.

 

Subjective Complaints of Dementia: Insight and Memory

Arvanitakis, Z., Leurgans, S. E., Fleischman, D. A., Schneider, J. A., Rajan, K. B., Pruzin, J. J., … & Bennett, D. A. (2018). Memory complaints, dementia, and neuropathology in older

blacks and whites. Annals of neurology, 83(4), 718-729.

Blom, K., Koek, H. L., Zwartbol, M. H., van der Graaf, Y., Kesseler, L., Biessels, G. J., … & de Borst, G. J. (2019). Subjective cognitive decline, brain imaging biomarkers, and cognitive

functioning in patients with a history of vascular disease: The SMART-Medea study. Neurobiology of aging, 84, 33-40.

Buckley, R. F., Hanseeuw, B., Schultz, A. P., Vannini, P., Aghjayan, S. L., Properzi, M. J., Jackson, J. D., Mormino, E. C., Rentz, D. M., Sperling, R. A., Johnson, K. A., & Amariglio, R. E.(2017). Region-Specific Association of Subjective Cognitive Decline With Tauopathy

Independent of Global β-Amyloid Burden. JAMA neurology, 74(12), 1455–1463.

https://doi.org/10.1001/jamaneurol.2017.2216

Goodwin G. M. (1997). Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression. Journal of psychopharmacology (Oxford,

England), 11(2), 115–122. https://doi.org/10.1177/026988119701100204

Jack Jr, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., … & Trojanowski, J. Q. (2010). Hypothetical model of dynamic biomarkers of the Alzheimer’s

pathological cascade.

The Lancet Neurology, 9(1), 119-128.Lee, Y.C., Kang, J.M., Lee, H. et al. Subjective cognitive decline and subsequent dementia: a nationwide cohort study of 579,710 people aged 66 years in South Korea. Alz Res Therapy 12, 52 (2020). https://doi.org/10.1186/s13195-020-00618-1

Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., … & Liu, E. (2018).

 

NIA-AA research framework: toward a biological definition of Alzheimer’s

disease. Alzheimers Dement 14 (4): 535–562.

Liew, T.M. Subjective cognitive decline, anxiety symptoms, and the risk of mild cognitive impairment and dementia. Alz Res Therapy 12, 107 (2020).

https://doi.org/10.1186/s13195-020-00673-8

Murman D. L. (2015). The Impact of Age on Cognition. Seminars in hearing, 36(3), 111–121. https://doi.org/10.1055/s-0035-1555115

Perrotin, A., Mormino, E. C., Madison, C. M., Hayenga, A. O., & Jagust, W. J. (2012). Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron

emission tomography study in normal elderly individuals. Archives of neurology, 69(2), 223-229.

Slot, R., Sikkes, S., Berkhof, J., Brodaty, H., Buckley, R., Cavedo, E., Dardiotis, E., Guillo-Benarous, F., Hampel, H., Kochan, N. A., Lista, S., Luck, T., Maruff, P., Molinuevo, J. L.,

Kornhuber, J., Reisberg, B., Riedel-Heller, S. G., Risacher, S. L., Roehr, S., Sachdev, P. S., … van der Flier, W. M. (2019). Subjective cognitive decline and rates of incident

Alzheimer’s disease and non-Alzheimer’s disease dementia. Alzheimer’s & dementia : the journal of the Alzheimer’s Association, 15(3), 465–476. https://doi.org/10.1016/j.jalz.2018.10.003

Van Etten, E. J., Bharadwaj, P. K., Nguyen, L. A., Hishaw, G. A., Trouard, T. P., & Alexander, G. E. (2020). Right hippocampal volume mediation of subjective memory complaints differs by hypertension status in healthy aging. Neurobiology of Aging, 94, 271-280.

 

Medical Issues that Contribute to Cognitive Impairment

Plassman, Annals of Internal Medicine, 2008

Doraiswamy et al. Prog Neuropsychopharmacol Biol Psychiatry 2002

[Prescribing Information] Accera Inc. 2009.

Jack CR, Jr., Holtzman DM. Biomarker modeling of Alzheimer’s disease. Neuron. 2013;80 (6):1347-1358.

Jak AJ, Bangen KJ, Wierenga CE, Delano-Wood L, Corey-Bloom J, Bondi MW. Contributions of neuropsychology and neuroimaging to understanding clinical subtypes of mild cognitive impairment. Int Rev Neurobiol. 2009;84:81-103.

Petersen RC, Knopman DS. MCI is a clinically useful concept. Int Psychogeriatr. 2006;18 (3):394-402; discussion 409-314.

Cerhan JR, Folsom AR, Mortimer JA, et al. Correlates of cognitive function in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Gerontology. 1998;44 (2):95-105.

The Importance of Non-Neurologic Symptoms in Dementia Care

Zarian, et al. J Natl Med Assoc 1989; 81(4): 373

Martin, et al. Aging & Ment Health 2019; 23(8): 1057

J Am Geriatr Soc 2019 Apr;67(4):674-694

Irwin et al. J Palliat Med 2013 Apr; 16(4): 423

 

Missed Diagnosis – Lost Opportunities

Bradford et al 2009. Alz Dis Assoc Disord

Harvard School of Public Health 2011

Hamlima 2016 JAGS

Carpenter et al 2008 JAGS

Baile et al. The Oncologist  Aug 2000

 

Incorporating a Dementia Strategy into your Practice

G Epstein-lubow – Health Affairs, 2014 – healthaffairs.org

AW Skipper, J Zanetos – Journal of gerontological nursing, 2019 – journals.healio.com

Alzheimer’s and Dementia Resources for Professionals webpage for more information on assessing cognitive impairment https://www.nia.nih.gov/health/alzheimers-dementia-resources-for-professionals 

CY 2018 Physician Fee Schedule final rule (82 FR 53077) replaced G0505 with CPT code 99483 https://www.govinfo.gov/content/pkg/FR-2017-11-15/pdf/2017-23953.pdf#page=102

CY 2021 Physician Fee Schedule final rule (85 FR 84472) modified CPT code 99483 by adding it as a permanent telehealth service, increasing its valuation, and defining it as a primary care service in the Medicare Shared Savings Program https://www.govinfo.gov/content/pkg/FR-2020-12-28/pdf/2020-26815. pdf#page=278 

Medicare Wellness Visits educational tool for more information about AWV’s https://www.cms.gov/ Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/preventive-services/medicarewellness-visits.html

 

Action Planning after a Dementia Diagnosis

 

“When Patients and Their Families Feel Like Hostages to Health Care” Leonard L. Berry, PhD, MBA; et. All Mayo Clinic Proceedings

 

N Engl J Med 2019; 381:2369-2370 Sarah H. Cross, M.S.W., M.P.H.
Duke University Sanford School of Public Policy, Durham, NC

07/29/2021, 05/20/2021, 04/01/2021, 03/11/2021, & 02/23/2021. (n.d.). Bringing meaning and purpose into the lives of elders through creative engagement. TimeSlips. https://www.timeslips.org/.

Brain Health I: The Sceince Behind Brain Health

 

Gomes-Osman et al. Neurol: ClinPrac 2018

Morris et al. Alzheimer’s& Dementia 2015

Vals-Pedret et al. JAMA 2015

Lehtisalo et al. Alzheimer’s & Dementia 2018

Middleton & Yaffe. Arch Neurol 2009

Yu et al. J NeurolNeurosurg Psychiatry 2019

 

Brain Health II: Agents of Change

 

Gill Livingston, et. al. Dementia Prevention, Intervention and Care. Lancet 2017: 390:2673-734.

Feart, Catherine, et al. “Adherence to a Mediterranean diet, cognitive decline, and risk of dementia.” JAMA 302.6 (2009): 638−648.

Psaltopoulou, Theodora, et al. “Mediterranean diet, stroke, cognitive impairment, and depression: a meta-analysis.” Annals of Neurology 74.4 (2013): 580−591. “Mediterranean-style diets linked to better brain function in older adults”

www.sciencedaily.com/releases/2017/07/170725154208.htm. UNESCO Intangible Cultural Heritage “Mediterranean Diet” ich.unesco.org/en/RL/mediterranean-diet-00884.

A John, K Ali, H Marsh, PH Reddy – Ageing research reviews, 2021 – Elsevier